-The Hindu Even as the Director-General of Foreign Trade issued a fresh notification lifting the ban on cotton exports, the government is set to launch a probe into the “self consignments,” mostly to China, and scrutinise the export receipt certificates (ERCs) to get to the root of the sudden spurt that caught it unawares. Though the government had registered 130 lakh bales for exports, it was only last week that the alarm...

-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision.  The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...

-The Business Standard Cotton export ban was an example of poor policy The government’s sudden move to ban cotton exports – rolled back in less than a week following anger from cotton farmers and adverse political fallout — reflects very poorly on its policy management. The commerce ministry clamped down on exports without clear logic; prior consultations with other ministries concerned were also cursory or non-existent. Unsurprisingly, most players in the cotton...

A recent report put out by the Association for Democratic Reforms and National Election Watch revealed that 47 per cent of the newly-elected Uttar Pradesh assembly has candidates with criminal cases pending against them.  Barring Manipur, none of the other four states that went to polls is free of a tainted MLA. In Uttar Pradesh, the number of criminal MLAs has gone up from 37 per cent in 2007 to 47...

-Reuters India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say.  On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug...